Introduction
============

Avian infectious bronchitis virus (IBV), the prototype species of the family *Coronaviridae*, causes an acute and highly contagious disease of chickens. Numerous IBV strains exist, and clinical signs of the disease they cause vary from mild to severe. More than 20 IBV serotypes have been recognized worldwide, which are defined by cross-reactivity among the structural proteins [@BIB14], [@BIB25]. Live vaccines containing strains of IBV from multiple serotypes are routinely used in commercial chicken flocks. Disease outbreaks in commercial flocks occur when new viruses emerge from existing viruses by mutations, insertions, deletions, or recombination [@BIB10], [@BIB17], [@BIB31]. However, because these conclusions are based on available sequence from structural genes, viral evolution has only been described for this small part of the genome. Because only two IBVs have been fully sequenced, it has been impossible to fully understand the viral evolutionary process including the extent to which vaccine viruses have contributed genetic material to pathogenic field strains.

Six subgenomic (sg) mRNA species are transcribed from the IBV genome in virus-infected cells. This includes a genome-length mRNA (mRNA 1) of 27.6 kb and five sg species (mRNA 2--6) with sizes ranging from 2 to 7 kb. These mRNAs form a 3′-co-terminal nested structure [@BIB54], each containing a short nontranslated leader sequence (64 nucleotides (nt)), derived from the 5′ end of the genome by a discontinuous process. The phenomenon of leader switching has been described for several coronaviruses including IBV [@BIB11], [@BIB44], [@BIB55]. The mRNA 1 contains two large overlapping open reading frames (ORF 1a and 1b) encoding 441- and 300-kDa polyproteins, respectively [@BIB2]. By a unique frameshifting mechanism, the downstream ORF 1b is produced as a fusion protein of 741 kDa with 1a [@BIB4], [@BIB5]. These polyproteins are proteolytically processed into smaller products required for RNA synthesis and other aspects of viral replication. Four main structural proteins are encoded by sgmRNAs: the spike (S) glycoprotein (mRNA 2), the small envelope (E) protein (mRNA 3), the membrane (M) glycoprotein (mRNA 4), and the nucleocapsid (N) protein (mRNA 6) [@BIB32], [@BIB52], [@BIB56]. The S1 fragment of the spike protein carries antigenic epitopes that induce virus-neutralizing (VN) antibody, and also determines virus serotype [@BIB6], [@BIB9].

Two overlapping papain-like proteinase (PL^pro^) domains encoded between nucleotides (nt) 4243 and 5553 (amino acids (aa) 1239--1675), and a picornavirus 3C-like proteinase (3C-LP) domain encoded between nt 8937 and 9357 (aa 2804--2943), are involved in the production of mature viral proteins required for replication [@BIB38], [@BIB39], [@BIB40], [@BIB41]. Proteolytic processing of the polyproteins by equivalent protease activities has been demonstrated in murine and human coronaviruses (reviewed in [@BIB37], [@BIB48]). Despite the conservation of function, there are some organizational differences in PL^pro^ domains between IBV and some other coronaviruses [@BIB22], [@BIB35]. Because of its key role in replicase gene expression, 3C-LP has been termed the coronavirus main protease (M^pro^; [@BIB60]). The IBV PL^pro^ domain-1 (PL1^pro^), encoded between nt 4243 and 5019 (aa 1239--1497), is responsible for cleavage of the N-terminal regions of 1a and 1a/1b polyproteins in IBV-infected cells, whereas the PL^pro^ domain-2 (PL2^pro^) encoded between nt 4681--5553 (aa 1385--1675) is reported to be functionally inactive in IBV [@BIB36], [@BIB37], [@BIB40]. A more important role in the processing of polyproteins is played by the M^pro^, which is responsible for the cleavage of other regions of the ORF 1a and 1a/1b polyproteins [@BIB39], [@BIB41], [@BIB42], [@BIB47], [@BIB49]. The catalytic center of both proteinases consists of His and Cys residues in all coronaviruses (reviewed in [@BIB37], [@BIB48]). The processed products constitute a group of replicative enzymes, including the RNA-dependent RNA polymerase (RdRp) and RNA helicase. Therefore, the significance of the coronavirus leader sequence and several putative functional domains essential for viral replication made them logical choices for sequence analysis and phylogenetic comparisons to correlate with the serological or pathological classification of coronaviruses.

Phylogeny-based clustering based on replicase genes is identical to the original antigen-based classification of coronaviruses [@BIB13], [@BIB21], [@BIB53]. However, within the group 3 coronaviruses, no comparisons of replicase-based and antigen-based phylogenies have been made. One report has described the alignment of the 5′-proximal region of replicase genes from a limited number of IBV strains [@BIB55], and a few reports describe IBV M^pro^ and RdRp domains from the Beaudette strain only [@BIB21], [@BIB53]. Here, we have sequenced four regions of the replicase gene corresponding to the 5′-terminal end, PL^pro^, M^pro^, and RdRp domains from 20 heterologous IBV strains, and compared then with previously published IBV and other coronavirus sequences. We present evidence that (i) the M^pro^ and RdRp regions are highly conserved among all coronaviruses unlike the 5′-terminal sequence and PL^pro^ domains, (ii) the clustering of heterologous IBV strains based on the replicase gene sequences does not correlate with the antigen-based S1 phylogeny, (iii) several widely used IBV vaccines and field strains isolated over the past decade have closely related replicase genes suggestive of a possible common ancestry or a converging evolution, and (iv) the replicase gene is unlikely to be the sole determinant of IBV pathogenicity.

Results
=======

The 5′-terminal sequences (nt 1--1263)
--------------------------------------

The nt sequence alignment data obtained from the IBV 5′-termini are presented in [Table 1](#TBL1){ref-type="table"} , [Fig. 1](#FIG1){ref-type="fig"}, [Fig. 2](#FIG2){ref-type="fig"} . The leader sequences (nt 1--64) of H52, CU705, CU510, Ark99, ArkDPI, CU805, CU570, GA98, Cal99, CU994, K1699, Gray, and BJ strains are identical to each other and each have 3 nt substitutions compared to the Beaudette strain [(Fig. 1)](#FIG1){ref-type="fig"}. The DE072 virus has four, the vaccine and challenge M41 strains, and CU-T2 have three, Ma5, K0751, and Florida have two, and Conn has a single nt substitution compared to the Beaudette strain [(Fig. 1)](#FIG1){ref-type="fig"}. The leader junction sequences termed as leader transcription-regulating sequences (TRSs) are absolutely conserved in all of the IBV strains compared. The sequence distance data [(Table 1)](#TBL1){ref-type="table"} obtained from the whole 5′ UTR (nt 1--528) indicate that nt sequence identities were 94--100% among all IBV strains in this region. The N-terminal coding region (nt 529--1263) of the 5′ terminal sequence is more variable with the lowest identity represented by the BJ strain at 84.6--86% identity with the other strains. Pairwise comparisons of the N-terminal sequences from other strains revealed 89.7--100% identity irrespective of serotype, geographic source, and virulence [(Table 1)](#TBL1){ref-type="table"}. The challenge strain NV M41 is identical to the vaccine strain M41 in the noncoding region but in the coding region has a single nt change that results in an amino acid change (data not shown). These relationships are graphically shown in the phylogenetic tree created from the nt sequences of the entire 5′ terminal region [(Fig. 2a)](#FIG2){ref-type="fig"} . No detectable sequence similarity was found when IBV 5′ terminal sequences were compared to those of coronaviruses from other groups (data not shown).Table 1Nucleotide identities in the 5′ UTR (nt 1--528: right-hand side) and the N-terminal coding region (nt 529--1263) of the replicase gene of 21 IBV strainsVirus5′ UTRBeauM41[a](#TBLFN1){ref-type="table-fn"}Ma5H52K0 751CU 705ConnCU 510FloriCU T2Ark 99Ark DPIDE 072CU 805CU 570GA 98Cal 99CU 994K1 699GraBJBeau**98.797.296.296.696.497.096.296.496.296.096.295.896.296.496.095.696.094.395.894.7**M41[a](#TBLFN1){ref-type="table-fn"}92.9**96.897.297.597.397.097.296.897.296.697.296.897.297.397.096.697.095.396.894.9**Ma594.693.3**99.699.298.797.299.296.698.597.299.699.298.999.499.499.199.496.099.295.1**H5294.693.3**10099.699.197.299.697.098.997.510099.699.299.899.899.499.896.499.695.5**K075194.193.2**99.399.399.197.599.297.399.297.599.699.299.299.499.499.199.496.299.295.3**CU70594.092.8**98.698.698.097.398.797.299.197.799.198.799.498.998.998.598.996.898.795.8**Conn94.493.3**98.298.297.697.197.299.497.297.397.296.897.297.097.096.697.095.196.894.2**CU51094.493.2**99.799.799.098.498.097.098.597.299.699.298.999.499.499.299.496.099.295.1**Florida94.493.3**98.298.297.697.199.798.097.097.297.096.697.096.896.896.496.8**94.9**96.694.0**CUT293.992.9**99.099.098.497.797.698.897.697.298.998.598.998.798.798.398.796.298.595.3**Ark9994.892.8**97.097.096.695.697.496.697.496.397.597.297.797.397.397.097.396.097.2**94.9ADPI94.793.2**99.999.999.298.898.199.698.198.996.999.699.299.899.899.499.896.499.695.5**DE07294.693.3**10010099.398.698.299.798.299.097.099.998.999.499.799.199.496.099.295.1**CU80593.592.5**97.897.897.196.796.397.796.396.995.697.797.899.199.198.799.196.698.996.0**CU57094.092.8**99.299.298.598.697.498.997.498.296.299.399.297.399.699.299.696.299.595.5**GA9894.693.1**99.799.799.098.698.299.598.298.897.099.999.797.699.299.299.696.299.395.3**Cal9994.893.6**99.799.799.098.498.599.198.598.897.399.699.797.698.999.599.295.899.195.1**CU99494.493.2**99.699.698.998.298.199.398.198.696.999.599.697.498.899.399.696.299.495.3**K169990.889.792.192.191.992.191.592.091.591.391.292.392.191.692.392.192.392.0**96.0**95.7Gray94.692.8**99.599.598.898.498.099.298.098.596.799.699.597.398.999.799.299.091.995.1**BJ84.884.685.885.885.584.685.685.885.685.485.085.685.885.285.295.585.985.686.085.2N-terminal coding region[^1][^2]Fig. 1Alignment of the first 80 nucleotides from cDNA sequences derived from the 5′ end of 22 heterologous IBV strains. The gray shading represents differences between sequences. The leader sequence is denoted by a solid black line above the sequence and the leader junction sequence is boxed.Fig. 2Phylogenetic trees showing the relatedness among the 5′-terminal sequences (a), PL^pro^ (b), M^pro^ (c), RdRp (d) domains and S1 glycoprotein genes (e) of 22 heterologous IBV strains. A cluster of contemporary field isolates and vaccine strains is indicated with a dashed box (⋯ ⋯) in a and in b. The neighbor-joining tree was constructed from the pairwise nucleotide differences for 5′-termini and deduced amino acid differences in all other respective genes. The length of each pair of branches represents the distance between sequence pairs. The scale at the bottom indicates the number of substitution events.

The PL^pro^ domains (nt 4243--5553: aa 1239--1675)
--------------------------------------------------

Sequence distance data derived from multiple alignments of the two overlapping PL^pro^ domains of IBV strains revealed 77.6--100% identity in PL1^pro^ and 79--100% in PL2^pro^, with the former being more variable than the latter [(Table 2)](#TBL2){ref-type="table"} . The BJ strain differed the most from other strains by 18.1--22.4% in PL1^pro^ and 16.5--21% in PL2^pro^. The catalytic Cys^1274^ and His^1437^ residues in the PL^pro^ domains are conserved in all IBV strains [(Fig. 3)](#FIG3){ref-type="fig"} . In the overlapping area of the PL^pro^ domains, a region of 24 residues with more heterogeneity has been identified, where only two residues (Phe^1470^ and Lys^1485^) are conserved among all IBV strains [(Fig. 3)](#FIG3){ref-type="fig"}. In this heterogeneous region, the vaccine and challenge M41 and BJ strains each differed by 12 aa (50%), Conn, CU510, Florida, CU805, and Gray each differed by 11 aa (45%), CU705, Ark99, and Cal99 strains each differed by 10 aa (40%), and all other strains are identical to each other and differed by 9 aa (37.5%) when compared to the Beaudette strain sequence. In the complete PL^pro^ domain, the NV M41 challenge strain has 1 nt and 1 aa difference from the M41 vaccine strain. The relationships between the different sequences are shown in the phylogenetic tree derived from analysis of the aa sequences of the entire PL^pro^ region (aa 1239--1675) [(Fig. 2b)](#FIG2){ref-type="fig"}. No detectable sequence similarity was found when IBV PL^pro^ sequences were compared to the PL^pro^ sequences of coronaviruses from other groups (data not shown).Table 2Amino acid identities in PL1^pro^ (aa 1239--1497) and PL2^pro^ (aa 1385--1675) of the replicase gene of 21 IBV strainsVirusPLPD-1BeauM41[a](#TBLFN2){ref-type="table-fn"}Ma5H52K0 751CU 705ConnCU 510FloriCUT2Ark99Ark DPIDE 072CU 805CU 570GA 98Cal99CU 994K1 699GraBJBeau88.883.483.482.681.587.381.987.385.387.383.083.082.283.083.081.983.085.787.380.7M41[a](#TBLFN2){ref-type="table-fn"}89.084.684.683.482.685.782.285.786.990.784.284.282.684.284.283.084.284.985.781.9Ma584.286.9**10096.598.1**84.2**96.5**84.291.184.9**99.699.295.899.699.697.3**99.686.984.280.3H5283.886.6**99.796.598.1**84.2**96.5**84.291.184.9**99.699.295.899.699.697.399.686.984.280.3**K075183.886.6**99.399.095.4**86.993.886.993.886.1**96.195.897.796.796.196.196.189.686.979.9**CU70583.285.9**99.099.398.3**82.2**96.1**82.289.283.8**97.997.394.697.797.795.497.784.982.279.9**Conn87.387.384.984.584.583.881.7**100**91.188.083.883.886.184.683.384.983.8**95.3100**77.6CU51082.884.9**96.696.995.996.9**82.881.987.683.8**96.198.5**93.1**96.196.1**93.8**96.1**83.881.978.4Florida87.387.384.984.584.583.8**99.9**82.891.188.083.883.886.194.683.384.983.8**95.3100**77.6CUT284.987.3**97.697.996.997.3**85.294.885.288.090.790.793.191.590.790.790.793.191.180.7Ark9987.689.784.584.284.283.592.882.892.884.984.684.684.685.384.684.984.987.688.081.5ADPI84.286.9**10099.799.399.0**84.9**96.6**84.9**97.6**84.5**98.895.499.299.296.999.2**86.583.880.3DE07283.586.3**99.099.398.398.6**84.2**96.2**84.2**97.6**83.8**99.095.098.899.396.598.8**86.583.879.9CU80582.584.9**97.397.396.697.6**82.8**95.5**82.8**95.5**82.5**97.396.996.195.495.495.4**88.886.178.8CU57083.886.6**99.799.399.098.6**84.5**96.2**84.5**97.3**84.2**99.798.696.999.296.999.2**87.384.679.9GA9883.886.6**99.799.399.098.6**84.5**96.2**84.5**97.3**84.2**99.798.696.999.397.7**99.286.583.879.9Cal9983.886.6**99.399.098.698.3**85.2**95.9**85.2**96.9**84.9**99.398.396.699.099.096.9**86.984.978.0CU99483.285.9**99.098.698.397.9**84.5**95.5**84.5**96.6**83.5**99.097.996.298.098.698.3**86.983.880.3K169981.482.884.283.883.683.282.882.182.884.983.584.283.582.583.883.883.884.290.380.7Gray86.986.984.584.284.283.5**99.7**82.5**99.7**84.992.484.583.882.884.284.284.984.282.577.6BJ81.183.581.481.180.880.480.879.080.882.182.581.480.879.781.181.181.181.482.180.4PLPD-2[^3][^4]Fig. 3Amino acid sequence alignment of the papain-like proteinase domains of 22 IBV strains indicating the catalytic Cys^1274^ and His^1437^ residues marked as asterisks (\*) and the more variable region marked by thick bar (**---**) below the alignment. Residue numbers are given above the sequence; four-digit numbers are ended at the labeled residue. The internal sequences not presented in this alignment are indicated by dashes (------).

The M^pro^ (aa ORF1a 2804--2943) and the RdRp (aa ORF1b 548--780) domains
-------------------------------------------------------------------------

The alignments of the deduced aa sequences of IBV M^pro^ and RdRp domains are summarized in [Table 3](#TBL3){ref-type="table"} . The overall sequences are highly conserved in which there are 82.7% (116 aa) absolutely conserved residues in M^pro^ and 92.7% (216 aa) absolutely conserved residues in RdRp (data not shown). The remaining 24 aa differences found in M^pro^ and 17 aa differences in RdRp are distributed throughout the domains [(Table 3)](#TBL3){ref-type="table"}. The M^pro^ and RdRp domains of ArkDPI, GA98, and Gray strains are identical to each other and those of the challenge NV M41 and vaccine M41 strains are also identical to each other. These relationships are graphically shown in the phylogenetic tree created from the aa sequences of the M^pro^ and RdRp domains [(Figs. 2c and d)](#FIG2){ref-type="fig"}.Table 3Amino acid exchanges in the main protease (aa ORF1a 2804--2943) and the RNA-dependent RNA polymerase (aa ORF1b 548--780) domains among 21 IBV strainsStrainsExchange of aa in the M^pro^ at position[a](#TBLFN3){ref-type="table-fn"}Exchange of aa in the RdRp at position[a](#TBLFN3){ref-type="table-fn"}281428152829283128352840284528472848284928512855286028742881289428982900290629252928292929352937569572592596606608611674678681698708744752754756765BeauTIQNNHTQHGTVKEIATVTVNINFEIAVSSIINSPLVFASEM41[b](#TBLFN4){ref-type="table-fn"}S..G..V.N\.....VS.I\...\...\....T.VD\...\.....Ma5\.....YV.NN\....VS..IP\...Y\....TP..DDS.IY.P.H52\...\...V.NN\....VS\...P\...Y\....TP..DDS.IYS..K0751\...S.YV.N\...RDVS\...\...\...\...T\...D\.....S..CU705\...\...V.NN\....VS..IP\...Y\....T\...D\.....S..Conn\...S..A.N\...RDVS\...\...\.....T\...D\.....S..CU510\...\...V.NN\....VS\...P.V.Y\....T\...D\.....S..Florida\...S..A.N\...RDVS\...\...\...\...T\...D\.....S..CUT2..HS..V.N\...RDVS\...\...\...\...T\...D\.....S..Ark99\...S..A.N.I.RDVS\...\...\...\...T\...D\.....S..ArkDPI\...S..A.N\...RDVS\...\...\...\...T\...D\.....SA.DE072\....Y.V.NN\....VS\...P\...Y\....TP..DDS.IY..GCU805\...\...V.NN\....VS\...P\...Y\...IT..VD\.....S..CU570\...S..A.N\...RDVSS\.....S\.....T\...D\.....S..GA98\...S..A.N\...RDVS\...\...\...\...T\...D\.....SA.Cal99\...\...V.NN..RDVS\...\.....A.V.T\...D\.....S..CU994\...S..A.N..RDVS\....T\.....V.T\...D\.....S..K1699.V.S..A.N..IRDVS\...\...\.....IT\...D\.....S..Gray\...S..A.N\...RDVS\...\...\...\...T\...D\.....SA.BJS..D..VGN\...R.MS.I\...\....M..T\...D..MIY\...[^5][^6]

By aligning with the corresponding regions of prototype members of other coronavirus groups, all M^pro^ had 28% (40 aa) absolutely conserved residues including catalytic Cys-His dyad and three substrate-binding sites (Tyr-Met-His), and the RdRp had 47.6% (111 aa) absolutely conserved residues (data not shown). The four RdRp motifs (DXXXD, SGXXXTXXXN, SDD, and K) appear to be fully conserved in all coronaviruses. The IBV M^pro^ domains have 38.7--40.1% similarity with 229E, 45.1--45.8% with TGEV, 38.5--41.5% with MHV, 39.2--41.5% with BoCV, and 43.4--44.8% with the SARS coronavirus in pairwise comparisons. Whereas the IBV RdRp has 60.9--62.7% similarity with 229E, 60.4--61.8% with TGEV, 66.5--68.7% with MHV, 66.1--68.2% with BoCV, and 66.1--68.2% with SARS coronavirus. The phylogenetic trees created from both M^pro^ and RdRp of various coronaviruses cluster into the three major antigenic groups (data not shown).

Discussion
==========

The findings of the present study can be summarized as: (i) the M^pro^ and RdRp regions are highly conserved among all coronaviruses unlike the 5′-terminal sequence and PL^pro^ domains, (ii) the clustering of heterologous IBV strains based on the replicase gene sequences does not correlate with the antigen-based S1 phylogeny, (iii) several widely used IBV vaccines and field strains isolated over the past decade have closely related replicase genes suggestive of a possible common ancestry or a converging evolution, and (iv) the replicase gene is unlikely to be the sole determinant of IBV pathogenicity.

Coronaviruses fall into three antigenic groups [@BIB15], which are defined by cross-reactivity among the structural proteins. Unlike the structural proteins, the coronavirus replicase gene is not subjected to immune selective pressure. Therefore, one would expect that the replicase gene would be highly conserved among coronavirus groups. In fact, this is the case when the M^pro^ and RdRp sequences are compared [(Table 3)](#TBL3){ref-type="table"} and as others have reported for other coronavirus groups [@BIB13], [@BIB19], [@BIB21], [@BIB53]. We found a high percentage of sequence similarities in coronavirus M^pro^ (with 28% absolutely conserved residues), including the substrate recognition site, and an even higher similarity in the RdRp (with 48% absolutely conserved residues), including the polymerase motifs. However, two-way sequence comparisons of the coronavirus 5′-termini and the PL^pro^ domains of ORF1a had very low sequence identity between coronaviruses of different groups as has been reported by others [@BIB23]. Despite the fact that these regions have varying degrees of genetic diversity, the relationships between the coronaviruses of different groups are the same, no matter what region of the genome is compared. When recombination occurs [@BIB7], it would seem to occur within the major coronaviruses antigenic groups, but not between them. This is expected because in order for recombination to occur, two viruses must be present in the same cell, which is unlikely between coronaviruses adapted to different host species. The highly conserved M^pro^-mediated processing pathways as well as the substrate binding sites of this enzyme in all coronaviruses [@BIB1], [@BIB21] make this proteinase an attractive target for the development of drugs directed against coronaviruses. The active domains of RdRp also maintain a high degree of homology among all coronaviruses, as has been found in other RNA viruses [@BIB30], [@BIB50], making this proteinase another potential target for drugs controlling coronaviruses.

With IBV, the phylogenies of the four regions of the replicase gene did not correlate with those of the S1 gene, which correspond to the type-specific antigenic groups [(Fig. 2)](#FIG2){ref-type="fig"}. For example, unlike the S1 genes, the replicase genes of the Ma5 and H52 Mass serotype viruses consistently clustered with those of non-Mass strains [(Figs. 2a--d)](#FIG2){ref-type="fig"}. The common clustering of replicase genes of these heterologous IBV strains could be due to an introduction of a replicase gene from a common source through introduction. Others have speculated that IBV strains substitute large genomic fragments in multiple genes [@BIB33] because the viability of the progeny viruses depends on the specific interactions of more than one gene working in concert to maintain structural and replicative integrity. Alternatively, it is probably more likely that the smaller S1 genes are exchanged between viruses through recombination and the stable replicase backbone is maintained. It is entirely possible that recombination events have occurred to introduce new replicase or new S1 genes into these viruses.

Leader acquisition in mRNA synthesis appears to be TRS dependent, and the leader-to-body joining is guided by a base-pairing interaction involving leader and body TRSs [@BIB24], [@BIB51]. The phenomenon of leader switching involves a recombination event over a region comprising the leader sequence and the adjacent 5′ UTR [@BIB12]. Previous reports have suggested that the leader sequences of IBV strains may contain higher (17.2%) substitution rates when compared to the complete 5′ UTR (4.3%; [@BIB55]). In our study, the 5′ UTR of all 22 IBV strains are highly conserved (94--100% identity), indicating the exchange of leader or adjacent 5′ UTR fragments has occurred in mixed infections. This observation is supported by experimental evidence of the exchange of leader sequences among heterologous IBV strains [@BIB55] and in mixed MHV infections [@BIB43]. The sequence comparison scores are more variable in the N-terminal coding region [(Table 1)](#TBL1){ref-type="table"}, and the most in PL^pro^ domains [(Table 2)](#TBL2){ref-type="table"} including a more variable region in the latter [(Fig. 3)](#FIG3){ref-type="fig"} than the IBV M^pro^ and RdRp domains [(Table 3)](#TBL3){ref-type="table"}. The reason for sequence variation in the N-terminal half of ORF1a among IBV strains is not clear.

The genetic variations in the 5′ terminal region and PL^pro^ gene suggest that there is some selective pressure on these regions. We speculate that there are some replicase genotypes that may confer a selective advantage to the virus. We examined both the 5′ terminal region and the PL^pro^ gene by year and location of isolation, but excluded the M^pro^ and RdRp genes because they are so highly conserved that no clear differences between isolates can be discerned. In the 5′ terminal region and the PL^pro^ gene, the IBV strains isolated from commercial chickens over the past decade cluster with three specific vaccine virus strains, ArkDPI, H52, and Ma5, no matter where in the United States they were isolated. There are three exceptions to this clustering, the 5′ terminal region of the Gray virus isolated in 1960 [@BIB57] clusters with modern field strains [(Fig. 2a)](#FIG2){ref-type="fig"}, although its PL^pro^ gene is more like the Conn and Florida reference viruses isolated in 1956 and 1971, respectively [@BIB29], [@BIB58] [(Fig. 2b)](#FIG2){ref-type="fig"}. In addition, there are two modern field isolates, one from China (BJ) and one from California (K1699) isolated in 2003 and 2001, respectively, that are outliers and do not appear to have 5′ termini or PL^pro^ genes that are related to other viruses [(Figs. 2a and b)](#FIG2){ref-type="fig"}. This common clustering of three widely used vaccines and IBV field isolates from the past decade suggests to us that there may be a common evolutionary progression in the 5′ terminal region and in the PL^pro^ gene. Although the 5′ terminal region genotype found in modern isolates was present in 1960, when the Gray virus was isolated, it appears to be more prevalent today. The question arises as to why this type of progression to a specific genotype would have occurred and how it could have happened. As to the question of why, we speculate that the more modern genotype must offer some fitness advantage to the virus. As to how it could have occurred, we consider the widespread use of multiple types of modified live vaccines in both the broiler and egg layer commercial poultry industries as the possible mechanism by which this modern replicase gene genotype was introduced. The Ark, Conn, and Mass (Ma5, H52) strains have been used simultaneously as live vaccines among commercial poultry [@BIB8]. Although we cannot prove or disprove that recombination has occurred, we can point to the evolutionary trends in the S1 gene as compared to the evolutionary trends in the replicase gene. The trends in S1 evolution have been toward ever increasing diversity [@BIB27], while it appears that the replicase gene is evolving to less variety between isolates. These juxtaposed evolutionary trends suggest that (1) these two regions are under very different selective pressures and thus undergo much different rates and modes of change, and (2) the exchange of genetic material may have occurred between vaccine strains and field isolates.

The genetic basis of IBV pathogenicity is not known. The role of the replicase gene in the virulence of IBV has not been established, and it is likely that some changes in the M^pro^ or viral polymerase would influence viral replication rate, and thus the pathogenic potential of a virus. In some RNA viruses, replicase genes are known to contain the determinants of species tropism and virulence factors [@BIB3], [@BIB20], [@BIB59]. In our study, there were no differences in any essential residues in M^pro^ and RdRp domains. In addition, we found that there was no clear relationship between viral pathotype and replicase genotype. As an example, the H52 vaccine strain is very closely related to the virulent DE072 isolate in all regions of the replicase (99.8% identity in the 5′ terminus, 99.5% in PL^pro^, 99.3% in M^pro^, 99.6% in RdRp) despite their differences in pathotype. In addition, a direct comparison of the replicase genes of the M41 challenge and vaccine strains where there were very few aa differences between the two strains with clearly different pathotypes. None of the aa changes between the two M41 strains were consistently observed in either all virulent or all avirulent strains. These findings would support our contention that the genotype of the replicase is not the sole determinant of pathogenicity among strains of IBV.

Materials and methods
=====================

Experimental design
-------------------

Twenty IBV strains from nine different serotypes, Mass (M41, NV M41, Ma5, H52, K0751, CU705), Conn (Conn, CU510), Florida, CU-T2, Arkansas (Ark-99, ArkDPI), Delaware 072 (DE072, CU805, CU570), Georgia 98 (GA98), California 99 (Cal99, CU994, K1699), and Gray, were used in this study [(Table 4)](#TBL4){ref-type="table"} . These virus strains were selected because they are very common vaccine and field strains that are frequently isolated from commercial chickens and are associated with clinical disease. All the reference IBV strains were obtained from Dr. Syed Naqi\'s laboratory (Cornell University, Ithaca), where they had been propagated in specific pathogen-free (SPF) embryonated chicken eggs to maintain the stock. In our laboratory, all of the viruses were also propagated in 9-day-old embryonated SPF eggs (Charles River SPAFAS, Wilmington, MA). Four regions of the replicase gene from 20 heterologous IBV strains, which correspond to the 5′-termini, and the PL^pro^, the M^pro^, and the RdRp domains [(Fig. 4)](#FIG4){ref-type="fig"} , were sequenced and compared with those of previously published IBV (Beaudette, BJ) and other coronavirus sequences.Table 4IBV strains examined in this studyStrain[a](#TBLFN5){ref-type="table-fn"}SerotypeGeographic originOriginal description or source (reference)GenBank accession no.[b](#TBLFN6){ref-type="table-fn"}BeaudetteMassachusettsNew Jersey, USALaboratory strain[c](#TBLFN7){ref-type="table-fn"}[M95169](M95169)M41MassachusettsMassachusetts, USA[@BIB29][AY561711](AY561711)NV M41MassachusettsUSAChallenge strain (NVSL, USDA)[AY561712](AY561712)Ma5MassachusettsEuropeVaccine strain[d](#TBLFN8){ref-type="table-fn"} (Intervet Inc.)[AY561713](AY561713)H52MassachusettsEuropeVaccine strain[d](#TBLFN8){ref-type="table-fn"} (Intervet Inc.)[AF352315](AF352315)K0751MassachusettsCalifornia, USAField isolate[e](#TBLFN9){ref-type="table-fn"} (UCDavis, 2001)[AY561714](AY561714)CU705MassachusettsNew York, USAField isolate[e](#TBLFN9){ref-type="table-fn"} (Cornell Univ., 2002)[AY561715](AY561715)ConnConnecticutConnecticut, USA[@BIB29][L18990](L18990)CU510ConnecticutNew York, USAField isolate[e](#TBLFN9){ref-type="table-fn"} (Cornell Univ., 2002)[AY561716](AY561716)FloridaFloridaFlorida, USA[@BIB58][AF027512](AF027512)CU-T2CU-T2New York, USA[@BIB26][U04739](U04739)Ark99ArkansasArkansas, USA[@BIB28][L10384](L10384)ArkDPIArkansasDelmarva, USA[@BIB16][AF006624](AF006624)DE072DE072Delmarva, USA[@BIB18][U77298](U77298)CU805DE072New York, USA[@BIB46][AF317215](AF317215)CU570DE072New York, USAField isolate[e](#TBLFN9){ref-type="table-fn"} (Cornell Univ., 2003)[AY561717](AY561717)GA98GA 98Georgia, USA[@BIB34][AF274437](AF274437)Cal99Cal99California, USA[@BIB45][AY514485](AY514485)CU994Cal99New Mexico, USAField isolate[e](#TBLFN9){ref-type="table-fn"} (Cornell Univ., 2000)[AF317499](AF317499)K1699Cal99California, USAField isolate[e](#TBLFN9){ref-type="table-fn"} (UCDavis, 2001)[AY561718](AY561718)GrayGrayDelmarva, USA[@BIB57][L14069](L14069)BJUnknownChinaGenBank (China, 2003)[AY319651](AY319651)[^7][^8][^9][^10][^11]Fig. 4Diagram of the coronavirus replicase gene (encoding ORF 1a and 1b) illustrating the 5′ untranslated region (UTR), papain-like proteinase (PL^pro^), main protease (M^pro^), RNA-dependent RNA polymerase (RdRp), metal-binding (MB), and RNA helicase (RH) domains. The arrows originating from PL^pro^ and M^pro^ indicate the cleavage sites. The four regions amplified in this study are indicated as shading areas with arrow at each end (bottom).

Viral RNA extraction, RT-PCR amplification and sequencing
---------------------------------------------------------

Genomic RNA was extracted from virus-inoculated allantoic fluid with TRIzol reagent (Invitrogen Co., Carlsbad, CA) following the manufacturer\'s instructions. The first strand cDNA synthesis and subsequent PCR were performed using GeneAmp RNA PCR kit (Perkin-Elmer Cetus, Norwalk, CT) following the manufacturer\'s instructions. The selected regions of the replicase genes were amplified with primers synthesized from conserved regions designed by aligning IBV Beaudette sequence and sequences from other coronaviruses. The PCR profiles involved an initial denaturation for 4 min at 94 °C followed by 35 cycles of annealing at 55 °C for 30 s, extension at 72 °C for 1 min, and melting at 94 °C for 1 min. The amplified products were directly sequenced at a commercial sequencing facility (Davis Sequencing, Davis, CA). The genome sense Pol32 (5′-CACTAGCCTTGCGCTAGA-3′) and anti-sense Pol1501 (5′-GACCAACCTTCTGGTTCAAC-3′) primers were used to amplify the 5′-termini that correspond to nt 32--1501 of the Beaudette sequence [@BIB2]. The 5′ ends of all IBV strains were amplified with FirstChoice RLM-RACE cDNA amplification kit (Ambion Inc., Austin, TX) using genomic antisense Pol1263 (5′-GCTTGCAAGACAAGTTCCTGC-3′) primer according to the manufacturer\'s protocol. The Pol1263 paired with another inner site primer Pol133 (5′-GGCACCTGGCCACCTGTCAGG-3′) selected from conserved areas (by aligning 11 IBV sequences including the Beaudette virus) could amplify nt 133--1263 (according to Beaudette sequence) of all IBV strains tested in our laboratory (data not shown). Three more consensus primer pairs were used to amplify other regions as follows: primers for the overlapping PL^pro^ amplification are PL55 (5′-AGGATAAAGAAATYCTCTTC-3′) and PL58 (5′-GGACCACAYAAAGAACCCTC-3′); primers for M^pro^ amplification are Mp51F (5′-CGCCACGTTACTCTATTGGT-3′) and Mp33 (5′-GCCGCATAGAGCCATGCTAC-3′); and primers for RdRp amplification are Rp52 (5′-CTACTATGACTAATAGGCAG-3′) and Rp31 (5′-CTGAGAAAGCTCTTGATAGAG-3′).

Sequence analysis
-----------------

Assembly of contiguous sequences, translation of nt sequence into protein sequence, and initial multiple sequence alignments were performed with Vector NTI Suite 9 software (InforMax, North Bethesda, MD). Selected sequences from GenBank were included in the alignment. After the alignment, the AlignX program constructs a phylogenetic tree employing the neighbor-joining method. Comparisons with published sequences were made by performing BlastN search (GenBank). Pairwise blast searches were also performed when there were no significant hits with BlastN search.

GenBank accession numbers
-------------------------

The accession numbers for IBV replicase gene sequences are as follows: (a) the 5′-termini: M41, [AY392047](AY392047); NV M41, [AY561719](AY561719); Ma5, [AY561720](AY561720); H52, [AY392048](AY392048); K0751, [AY561721](AY561721); CU705, [AY561722](AY561722); Conn, [AY392049](AY392049); CU510, [AY561723](AY561723); Florida, [AY392050](AY392050); CU-T2, [AY561724](AY561724); Ark99, [AY392051](AY392051); ArkDPI, [AY392052](AY392052); DE072, [AY392054](AY392054); CU805, [AY561725](AY561725); CU570, [AY561726](AY561726); GA98, [AY392053](AY392053); Cal99, [AY392055](AY392055); CU994, [AY561727](AY561727); K1699, [AY561728](AY561728); Gray, [AY392056](AY392056); (b) the PL^pro^: M41, [AY392057](AY392057); NV M41, [AY561729](AY561729); Ma5, [AY561730](AY561730); H52, [AY392058](AY392058); K0751, [AY561731](AY561731); CU705, [AY561732](AY561732); Conn, [AY392059](AY392059); CU510, [AY561733](AY561733); Florida, [AY392060](AY392060); CU-T2, [AY561734](AY561734); Ark99, [AY392061](AY392061); ArkDPI, [AY392062](AY392062); DE072, [AY392064](AY392064); CU805, [AY561735](AY561735); CU570, [AY561736](AY561736); GA98, [AY392063](AY392063); Cal99, [AY392065](AY392065); CU994, [AY561737](AY561737); K1699, [AY561738](AY561738); Gray, [AY392066](AY392066); (c) the M^pro^: M41, [AY392067](AY392067); NV M41, [AY561739](AY561739); Ma5, [AY561740](AY561740); H52, [AY392068](AY392068); K0751, [AY561741](AY561741); CU705, [AY561742](AY561742); Conn, [AY392069](AY392069); CU510, [AY561743](AY561743); Florida, [AY392070](AY392070); CU-T2, [AY561744](AY561744); Ark99, [AY392071](AY392071); ArkDPI, [AY392072](AY392072); DE072, [AY392074](AY392074); CU805, [AY561745](AY561745); CU570, [AY561746](AY561746); GA98, [AY392073](AY392073); Cal99, [AY392075](AY392075); CU994, [AY561747](AY561747); K1699, [AY561748](AY561748); Gray, [AY392076](AY392076); (d) the RdRp: M41, [AY392077](AY392077); NV M41, [AY561749](AY561749); Ma5, [AY561750](AY561750); H52, [AY392078](AY392078); K0751, [AY561751](AY561751); CU705, [AY561752](AY561752); Conn, [AY392079](AY392079); CU510, [AY561733](AY561733); Florida, [AY392080](AY392080); CU-T2, [AY561754](AY561754); Ark99, [AY392081](AY392081); ArkDPI, [AY392082](AY392082); DE072, [AY392084](AY392084); CU805, [AY561755](AY561755); CU570, [AY561756](AY561756); GA98, [AY392083](AY392083); Cal99, [AY392085](AY392085); CU994, [AY561757](AY561757); K1699, [AY561758](AY561758); Gray, [AY392086](AY392086).

The complete genome sequences of Beaudette ([M95169](M95169)) and BJ ([AY319651](AY319651)) strains of IBV, HcoV 229E ([NC_002645](NC_002645)), TGEV ([NC_002306](NC_002306)), MHV ([NC_001846](NC_001846)), BoCV ([NC_003045](NC_003045)), and SARS ([NC_004718](NC_004718)) were obtained from GenBank. The S1 sequences of IBV strains were also obtained from GenBank [(Table 4)](#TBL4){ref-type="table"}.
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[^1]: Sequences with \>95% identity are indicated in bold letters.

[^2]: Because of the overall sequence identity of the vaccine and challenge strains of M41, for brevity, only the vaccine strain is included in this table.

[^3]: Sequences with \>95% identity are indicated in bold letters.

[^4]: Because of the overall sequence identity of the vaccine and challenge strains of M41, for brevity, only the vaccine strain is included in this table.

[^5]: Amino acid residues identical to that of Beaudette virus are indicated as dots (.).

[^6]: Because of the overall sequence identity of the vaccine and challenge strains of M41, for brevity, only the vaccine strain is included in this table.

[^7]: Except for the Gray strain that is nephrotropic and the BJ strain whose tissue tropism is unknown, all other strains are pneumotropic.

[^8]: Based on S1 gene sequence.

[^9]: Extensively propagated in vitro since the first isolation [@BIB61] and known to be attenuated.

[^10]: Introduced to the US market at about 1990 (Ma5) and 1980 (H52).

[^11]: IBV recovered from infected chicken flocks and associated with clinical disease and their serotype determined by S1 sequence.
